148 related articles for article (PubMed ID: 27374455)
1. Silencing NKD2 by Promoter Region Hypermethylation Promotes Esophageal Cancer Progression by Activating Wnt Signaling.
Cao B; Yang W; Jin Y; Zhang M; He T; Zhan Q; Herman JG; Zhong G; Guo M
J Thorac Oncol; 2016 Nov; 11(11):1912-1926. PubMed ID: 27374455
[TBL] [Abstract][Full Text] [Related]
2. Methylation of DACT2 accelerates esophageal cancer development by activating Wnt signaling.
Zhang M; Linghu E; Zhan Q; He T; Cao B; Brock MV; Herman JG; Xiang R; Guo M
Oncotarget; 2016 Apr; 7(14):17957-69. PubMed ID: 26919254
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic silencing of NKD2, a major component of Wnt signaling, promotes breast cancer growth.
Dong Y; Cao B; Zhang M; Han W; Herman JG; Fuks F; Zhao Y; Guo M
Oncotarget; 2015 Sep; 6(26):22126-38. PubMed ID: 26124080
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic silencing of JAM3 promotes esophageal cancer development by activating Wnt signaling.
Yang W; Guo C; Herman JG; Zhu C; Lv H; Su X; Zhang L; Zhang M; Guo M
Clin Epigenetics; 2022 Dec; 14(1):164. PubMed ID: 36461092
[TBL] [Abstract][Full Text] [Related]
5. Silencing NKD2 by promoter region hypermethylation promotes gastric cancer invasion and metastasis by up-regulating SOX18 in human gastric cancer.
Jia Y; Cao B; Yang Y; Linghu E; Zhan Q; Lu Y; Yu Y; Herman JG; Guo M
Oncotarget; 2015 Oct; 6(32):33470-85. PubMed ID: 26396173
[TBL] [Abstract][Full Text] [Related]
6. [The role of hypermethylation in promoter region of ubiquitin carboxyl-terminal hydrolase L1 in human esophageal cancer].
Yan WJ; Guo MZ; Yang YS
Zhonghua Nei Ke Za Zhi; 2012 May; 51(5):390-3. PubMed ID: 22883340
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic silencing of IGFBPL1 promotes esophageal cancer growth by activating PI3K-AKT signaling.
Liu Y; Zhang M; He T; Yang W; Wang L; Zhang L; Guo M
Clin Epigenetics; 2020 Feb; 12(1):22. PubMed ID: 32041673
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic silencing of RASSF10 promotes tumor growth in esophageal squamous cell carcinoma.
Lu D; Ma J; Zhan Q; Li Y; Qin J; Guo M
Discov Med; 2014 Apr; 17(94):169-78. PubMed ID: 24759621
[TBL] [Abstract][Full Text] [Related]
9. XAF1 is frequently methylated in human esophageal cancer.
Chen XY; He QY; Guo MZ
World J Gastroenterol; 2012 Jun; 18(22):2844-9. PubMed ID: 22719195
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic silencing of TMEM176A promotes esophageal squamous cell cancer development.
Wang Y; Zhang Y; Herman JG; Linghu E; Guo M
Oncotarget; 2017 Sep; 8(41):70035-70048. PubMed ID: 29050260
[TBL] [Abstract][Full Text] [Related]
11. Methylation of NRN1 is a novel synthetic lethal marker of PI3K-Akt-mTOR and ATR inhibitors in esophageal cancer.
Du W; Gao A; Herman JG; Wang L; Zhang L; Jiao S; Guo M
Cancer Sci; 2021 Jul; 112(7):2870-2883. PubMed ID: 33931924
[TBL] [Abstract][Full Text] [Related]
12. Methylation of DACT2 promotes breast cancer development by activating Wnt signaling.
Li J; Zhang M; He T; Li H; Cao T; Zheng L; Guo M
Sci Rep; 2017 Jun; 7(1):3325. PubMed ID: 28607412
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic inactivation of secreted frizzled-related protein 2 in esophageal squamous cell carcinoma.
Hao XW; Zhu ST; He YL; Li P; Wang YJ; Zhang ST
World J Gastroenterol; 2012 Feb; 18(6):532-40. PubMed ID: 22363119
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of SOX17 by microRNA 141 and methylation activates the WNT signaling pathway in esophageal cancer.
Jia Y; Yang Y; Zhan Q; Brock MV; Zheng X; Yu Y; Herman JG; Guo M
J Mol Diagn; 2012 Nov; 14(6):577-85. PubMed ID: 22921431
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic silencing of TMEM176A activates ERK signaling in human hepatocellular carcinoma.
Li H; Zhang M; Linghu E; Zhou F; Herman JG; Hu L; Guo M
Clin Epigenetics; 2018 Nov; 10(1):137. PubMed ID: 30400968
[TBL] [Abstract][Full Text] [Related]
16. Methylation of
Zheng R; Gao D; He T; Zhang M; Zhang X; Linghu E; Wei L; Guo M
Clin Epigenetics; 2017; 9():50. PubMed ID: 28491151
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation of the Wnt signaling inhibitor DACT2 in human hepatocellular carcinoma.
Zhang X; Yang Y; Liu X; Herman JG; Brock MV; Licchesi JD; Yue W; Pei X; Guo M
Epigenetics; 2013 Apr; 8(4):373-82. PubMed ID: 23449122
[TBL] [Abstract][Full Text] [Related]
18. Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth.
Wang Y; He T; Herman JG; Linghu E; Yang Y; Fuks F; Zhou F; Song L; Guo M
Clin Epigenetics; 2017; 9():115. PubMed ID: 29075358
[TBL] [Abstract][Full Text] [Related]
19. LINC00922 regulates epithelial-mesenchymal transition, invasive and migratory capacities in breast cancer through promoting NKD2 methylation.
Wang Y; Dong T; Wang P; Li S; Wu G; Zhou J; Wang Z
Cell Signal; 2021 Jan; 77():109808. PubMed ID: 33045317
[TBL] [Abstract][Full Text] [Related]
20. Methylation of DACT2 promotes papillary thyroid cancer metastasis by activating Wnt signaling.
Zhao Z; Herman JG; Brock MV; Sheng J; Zhang M; Liu B; Guo M
PLoS One; 2014; 9(11):e112336. PubMed ID: 25375359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
